The Continuing Battle for Universal Pharmacare with Marc-André Gagnon
Bill C-64 promises to bring pharmacare to Canadians, but gaps within the legislation may prevent it from fulfilling true universal pharmacare for all.
Pharmacare
-
-
Pharmacare and Access to Medicines in Canada: Is Bill C-64 a Step in the Right Direction?
After years of change and advancement in healthcare for Canadian citizens, Bill C-64 still might fall short of adequately and fairly providing pharmacare in Canada.
-
Pharmacare Showdown with MP Don Davies
NDP members voted to withdraw support for the Liberal Confidence and Supply Agreement in Parliament if Pharmacare is not implemented. After the vote, what’s next?
-
Reigning in drug prices, before pharmacare slips away
Canada has long suffered from a broken pricing regime for prescription drugs. Now is the time for a new regime, one that supports the scientific community, encourages economic development and job creation.
-
Steps must be taken to nationalize pharmaceutical production in Canada
It’s time we stopped being prisoners of foolish economic orthodoxies. A publicly-owned pharmaceutical company always made sense – and does so now more than ever.
-
Completing the promise of Medicare
As the federal government thinks about how to fill the holes in our social safety net that the pandemic has revealed, the creation of universal Pharmacare should be top of the priority list.
-
The TPP: a secret deal that binds the hands that heal
The growing call for universal drug coverage stems from the realization that Canadians should be able to take medications as prescribed, regardless of their financial situation.
